Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2019 May 14;7(8):2624–2633.e2. doi: 10.1016/j.jaip.2019.04.043

Table 2.

Associations between single non-invasive Type-2 inflammatory markers and an acute visit for asthma by 12 months (primary outcome).

Age group Predictor % with outcome Crude OR
(95% CI)
Adjusted OR1
(95% CI)
Sensitivity Specificity
Children 5–11 years Elevated blood eosinophils
 ≥ 150 cells/microliter 40.4 2.68 (2.07, 3.46)* 2.39 (1.83, 3.13)* 0.848 0.312
 ≥ 200 cells/microliter 40.4 1.81 (1.47, 2.22)* 1.66 (1.33, 2.06)* 0.707 0.437
 ≥ 250 cells/microliter 41.1 1.74 (1.43, 2.12)* 1.51 (1.23, 1.87)* 0.627 0.509
 ≥ 300 cells/microliter 39.8 1.42 (1.17, 1.73)* 1.19 (0.97, 1.46) 0.510 0.578
Elevated exhaled nitric oxide2 35.2 0.99 (0.80, 1.22) 0.97 (0.78, 1.22) 0.293 0.708
Elevated serum IgE
 ≥ 100 kU/L 35.7 1.06 (0.84, 1.35) 0.99 (0.77, 1.28) 0.777 0.246
 ≥ 200 kU/L 35.5 1.00 (0.82, 1.23) 0.86 (0.69, 1.08) 0.648 0.360
 ≥ 300 kU/L 35.8 1.04 (0.85, 1.26) 0.92 (0.75, 1.14) 0.547 0.465
Aeroallergen sensitization
 Any sensitization 37.4 1.84 (1.37, 2.47)* 1.65 (1.21, 2.25)* 0.893 0.188
 Multiple sensitization 38.2 1.64 (1.30, 2.08)* 1.49 (1.17, 1.91)* 0.694 0.426
Adolescents 12–21 years Elevated blood eosinophils
 ≥ 150 cells/microliter 28.7 1.98 (1.54, 2.55)* 1.50 (1.13, 1.98)* 0.772 0.392
 ≥ 200 cells/microliter 31.5 2.46 (1.93, 3.12)* 1.82 (1.40, 2.36)* 0.727 0.492
 ≥ 250 cells/microliter 32.5 2.24 (1.79, 2.80)* 1.61 (1.26, 2.07)* 0.621 0.586
 ≥ 300 cells/microliter 35.7 2.53 (2.03, 3.16)* 2.04 (1.60, 2.60)* 0.555 0.687
Elevated exhaled nitric oxide2 31.3 1.59 (1.26, 2.00)* 1.24 (0.95, 1.61) 0.354 0.757
Elevated serum IgE
 ≥ 100 kU/L 28.3 2.00 (1.54, 2.61)* 1.43 (1.06, 1.92)* 0.769 0.361
 ≥ 200 kU/L 27.7 1.47 (1.17, 1.85)* 1.04 (0.81, 1.35) 0.628 0.461
 ≥ 300 kU/L 28.0 1.44 (1.16, 1.80)* 1.07 (0.84, 1.37) 0.555 0.535
Aeroallergen sensitization
 Any sensitization 29.3 4.69 (3.17, 6.93)* 2.39 (1.54, 3.71)* 0.928 0.263
 Multiple sensitization 30.8 4.06 (2.95, 5.58)* 2.31 (1.63, 3.28)* 0.730 0.438
*

p < 0.05

OR = odds ratio, CI = confidence interval

1

Adjusted for sex, ethnicity, race, household education level, tobacco smoke exposure, and ICS use.

2

Defined as ≥35 ppb for children 5–11 years and ≥50 ppb for adolescents 12–21 years